FARALLON CAPITAL MANAGEMENT LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$166,701,744
+20.8%
1,375,200
+14.1%
0.84%
+16.6%
Q2 2023$138,019,504
+9.6%
1,205,200
+32.0%
0.72%
+3.0%
Q1 2023$125,880,139
+4.6%
913,300
-1.7%
0.70%
-3.1%
Q4 2022$120,366,862
+44.2%
928,900
+23.0%
0.72%
+55.4%
Q3 2022$83,452,000
-6.1%
754,950
-36.3%
0.46%
-4.7%
Q2 2022$88,831,000
+14.6%
1,185,051
+19.5%
0.48%
+29.7%
Q1 2022$77,493,000
+2.6%
991,975
+18.2%
0.37%
-0.8%
Q4 2021$75,553,000
+404.3%
839,009
+417.9%
0.38%
+438.6%
Q3 2021$14,982,000
-33.0%
162,000
-46.0%
0.07%
-36.9%
Q1 2021$22,359,000
-78.1%
300,000
-50.0%
0.11%
-82.0%
Q4 2020$102,294,000
+21.4%
600,0000.0%0.62%
+5.5%
Q3 2020$84,258,000
+0.1%
600,000
+14.3%
0.58%
-13.5%
Q2 2020$84,179,000
+145.9%
525,000
+50.0%
0.67%
+129.3%
Q1 2020$34,237,000
-33.7%
350,000
-12.5%
0.29%
-15.5%
Q4 2019$51,616,000
-32.1%
400,000
-20.0%
0.35%
-29.6%
Q2 2019$75,975,000
-1.9%
500,000
-23.1%
0.49%
-15.3%
Q1 2019$77,474,000
+10.9%
650,000
+1.6%
0.58%
+13.9%
Q4 2018$69,843,000
+121.8%
640,000
+228.2%
0.51%
+175.3%
Q3 2018$31,494,000195,0000.19%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders